RAC reviews serious adverse event associated with AAV therapy trial.
Williams
David A
DA
D026683:Advisory Committees; D000229:Dependovirus / Q000235:genetics*; D015316:Genetic Therapy / Q000009:adverse effects*; D006801:Humans